Cargando…

Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification

Radiotherapy for prophylaxis of heterotopic ossification (HO) is commonly used in high risk patients following orthopedic surgery. While treatment is effective and can prevent morbidity associated with HO, with any dose of radiation there is a concern of a radiation induced malignancy. Here we a rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Farris, Michael K, Chowdhry, Varun K, Lemke, Sheila, Kilpatrick, Mary, Lacombe, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488033/
https://www.ncbi.nlm.nih.gov/pubmed/22908888
http://dx.doi.org/10.1186/1748-717X-7-140
_version_ 1782248571079229440
author Farris, Michael K
Chowdhry, Varun K
Lemke, Sheila
Kilpatrick, Mary
Lacombe, Michael
author_facet Farris, Michael K
Chowdhry, Varun K
Lemke, Sheila
Kilpatrick, Mary
Lacombe, Michael
author_sort Farris, Michael K
collection PubMed
description Radiotherapy for prophylaxis of heterotopic ossification (HO) is commonly used in high risk patients following orthopedic surgery. While treatment is effective and can prevent morbidity associated with HO, with any dose of radiation there is a concern of a radiation induced malignancy. Here we a report a case of radiation induced osteosarcoma which developed 11 years after a single fraction of 700 cGy. We performed dosimetric analysis by superimposing the patient’s original treatment field on a CT scan performed after the diagnosis. The radiotherapy dose for this patient is lower than classically reported for radiation induced sarcomas. We identified greatest bony destruction that was thought to be the epicenter of the tumor, and this was specially contoured on the diagnostic CT scan. This volume appears to be located at the edge of the radiotherapy field. Fifty percent of the treated volume received 240 cGy, the mean dose was 333 cGy. There was a variation across the treatment volume, between 21.8 cGy and 717 cGy. While a rare complication, we stress the importance of informing regarding the risk of a radiation induced malignancy following HO prophylaxis.
format Online
Article
Text
id pubmed-3488033
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34880332012-11-03 Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification Farris, Michael K Chowdhry, Varun K Lemke, Sheila Kilpatrick, Mary Lacombe, Michael Radiat Oncol Case Report Radiotherapy for prophylaxis of heterotopic ossification (HO) is commonly used in high risk patients following orthopedic surgery. While treatment is effective and can prevent morbidity associated with HO, with any dose of radiation there is a concern of a radiation induced malignancy. Here we a report a case of radiation induced osteosarcoma which developed 11 years after a single fraction of 700 cGy. We performed dosimetric analysis by superimposing the patient’s original treatment field on a CT scan performed after the diagnosis. The radiotherapy dose for this patient is lower than classically reported for radiation induced sarcomas. We identified greatest bony destruction that was thought to be the epicenter of the tumor, and this was specially contoured on the diagnostic CT scan. This volume appears to be located at the edge of the radiotherapy field. Fifty percent of the treated volume received 240 cGy, the mean dose was 333 cGy. There was a variation across the treatment volume, between 21.8 cGy and 717 cGy. While a rare complication, we stress the importance of informing regarding the risk of a radiation induced malignancy following HO prophylaxis. BioMed Central 2012-08-21 /pmc/articles/PMC3488033/ /pubmed/22908888 http://dx.doi.org/10.1186/1748-717X-7-140 Text en Copyright ©2012 Farris et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Farris, Michael K
Chowdhry, Varun K
Lemke, Sheila
Kilpatrick, Mary
Lacombe, Michael
Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification
title Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification
title_full Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification
title_fullStr Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification
title_full_unstemmed Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification
title_short Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification
title_sort osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488033/
https://www.ncbi.nlm.nih.gov/pubmed/22908888
http://dx.doi.org/10.1186/1748-717X-7-140
work_keys_str_mv AT farrismichaelk osteosarcomafollowingsinglefractionradiationprophylaxisforheterotopicossification
AT chowdhryvarunk osteosarcomafollowingsinglefractionradiationprophylaxisforheterotopicossification
AT lemkesheila osteosarcomafollowingsinglefractionradiationprophylaxisforheterotopicossification
AT kilpatrickmary osteosarcomafollowingsinglefractionradiationprophylaxisforheterotopicossification
AT lacombemichael osteosarcomafollowingsinglefractionradiationprophylaxisforheterotopicossification